These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28093879)

  • 21. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproate-Associated Hyperammonaemic Encephalopathy.
    Anthonipillai P; Sharp G; Kimber J; Ziauddin V
    Acute Med; 2022; 21(1):43-46. PubMed ID: 35342909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report.
    Pokorná P; Hronová K; Šíma M; Slanař O; Klement P; van den Anker JN; Tibboel D
    Eur J Clin Pharmacol; 2017 May; 73(5):647-649. PubMed ID: 28168312
    [No Abstract]   [Full Text] [Related]  

  • 25. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid and zonisamide induced hyperammonemic encephalopathy.
    Ilieva HS; Newman JW; Fields RK; Croom JE
    Clin Neurol Neurosurg; 2020 Sep; 196():105894. PubMed ID: 32645624
    [No Abstract]   [Full Text] [Related]  

  • 27. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2015 May; 177(20):945-6. PubMed ID: 26535436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid-induced hyperammonemia: a case report.
    McCall M; Bourgeois JA
    J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Encephalopathies caused by valproate].
    Göbel R; Görtzen A; Bräunig P
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Valproate-caused encephalopathy].
    Thygesen KS; Wolf P
    Ugeskr Laeger; 2005 Oct; 167(40):3793-4. PubMed ID: 16221398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperammonemic encephalopathy induced by valproic acid.
    Zhu QM; Singh AK; Chang HR; Konka SA
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Encephalopathy induced by ingestion of ammonium during valproate therapy].
    Dumont O; Plauchu G; Scoazec JY; Cuber JC; Guegen L; Paliard P; Dumortier J
    Gastroenterol Clin Biol; 2001 Mar; 25(3):325-7. PubMed ID: 11395684
    [No Abstract]   [Full Text] [Related]  

  • 36. [A valproate-induced encephalopathy without hyperammonemia].
    Parize P; Beuret P; Fischer C
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1084-5. PubMed ID: 18029137
    [No Abstract]   [Full Text] [Related]  

  • 37. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
    Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-hyperammonaemia valproate-induced encephalopathy: A case report.
    Chen L; Xu Z; Huang H
    J Clin Pharm Ther; 2022 Mar; 47(3):415-419. PubMed ID: 34462930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperammonaemic encephalopathy and a flat electroencephalogram caused by valproic acid.
    Belze O; Remérand F; Pujol A; Fusciardi J
    Acta Anaesthesiol Scand; 2013 Sep; 57(8):1084. PubMed ID: 23713766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.